Adalimumab Precautions and Warnings
Before taking adalimumab, (Humira) patients should discuss with their physician about any possible precautions or warnings that may be associated with the medication. Adalimumab may increase the risk of serious infections, dangerously low blood counts, hepatitis B, tuberculosis, and congestive heart failure. Patients should consult with their physician about any prescription or over-the-counter medications they are currently taking, as some medications are known to interact with adalimumab. For a complete list of precautions and warnings associated with adalimumab, see the following links below.
- Patients with a history of cancer, congestive heart failure, diabetes, HIV, allergies, hepatitis B, tuberculosis, recent infections, and blood clotting disorders should use caution when taking adalimumab.
- Wheezing, hives, trouble breathing, and pruritis may also occur in patients taking adalimumab.
- Patients should not receive a live vaccine while taking adalimumab.
- Adalimumab is a prescription medication used to treat certain autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, and psoriatic arthritis.